Chromatic techniques for in vivo monitoring jaundice in neonate tissues by Sufian, AT et al.
Chromatic techniques for in-vivo monitoring jaundice in 
neonate tissues  
A T Sufian1, G R Jones1, H M Shabeer2, E Y Elzagzoug1, J W Spencer1 
1 Department of Electrical Engineering and Electronics, Centre for Intelligent Monitoring Systems, 
University of Liverpool, Liverpool L69 3GJ, UK 
2 Thegana Medical Mission Hospital & Research Centre, Perumpanachy. P.O, Changanacherry, 
Kottayam, Kerala, India.  
 
E-mail: a.sufian@liverpool.ac.uk 
 
Abstract 
 
A chromatic method is described for providing a preliminary indication of unacceptable bilirubin levels 
in a newly born baby in order to avoid the development of serious mental deficiencies. The aim was to 
investigate the reliability of a new chromatic approach using a novel template unit for a preliminary, 
non-invasive monitoring of the skin tissue of newly born babies with jaundice and its capability for use 
with different mobile phone cameras. A description of the monitoring system is given along with an 
explanation of the monitoring technique used. 
Preliminary tests have been performed on 48 different neonates each being addressed by one of 6 
different mobile phone cameras, which were randomly available to the operating clinicians 
The significance of the results obtained is that they show the approach to have a high level of fail-safe 
reliability in indicating the bilirubin levels when compared with blood test results. The test results have 
a correlation (R2) of 0.81, a Sensitivity (Sn) of 0.97, a Specificity (Sp) of 0.82, a Positive Predictive 
value (PPV) of 0.95 and a Negative Predictive Value (NPV) of 0.9. The results also show that the 
approach can be used with a few different mobile phone cameras and that because of its non-invasive 
nature and its cost effectiveness, has the potential for remote use from a medical hospital to provide an 
immediate preliminary diagnosis.  
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1. Introduction  
 
Although the  occurrence of jaundice in newly born babies could lead to severe brain damage (Dennery 
et al 2001, Polley N et. al 2015) prolonged hospitalisation for bilirubin blood testing (Total Serum 
Bilirubin TSB) to check for unacceptable jaundice levels (typically > 10 mg/dl) for many babies is not 
necessary (Dennery et al, 2001). Because such blood testing is invasive it is painful and stressful for the 
neonate and can result in blood loss and increased risk of developing infections (Dai et al, 1997, Lilien 
et al 1976). A non-invasive, less laborious and time consuming means of providing an immediate, 
preliminary diagnosis is therefore desirable. 
Possible alternatives to invasive blood sampling have been reported which are in vivo, non-invasive 
and optically addressing various tissue areas on the torso of newly born babies (Transcutaneous 
Bilirubinometry (TcB)). Such methods use various optical techniques to monitor the absorbance of 
various optical wavelengths for indicating the bilirubin concentration. Various approaches use different 
types of light sources (Xenon, Tungsten Halogen, Light Emitting Diodes (LEDs)) with various forms 
of optical spectroscopy to address different torso areas such as the eye conjunctiva, ear lobes, nose, 
forehead, and abdomen. 
The first transcutaneous bilirubin meter was introduced in 1980 (Yamanouchi et al, 1980) and since 
then, several other devices have been developed (Yasuda et al 2013, Tayaba et al 1998, Rubaltelli et al 
2001, De Luca et al 2008, Bertini et al 2008, Petersen et al 2015). Bosschart et al 2011 used a tungsten 
halogen source with an optical fiber probe and spectrograph. Polley et al 2015 used optical fibre probes 
and a spectrograph for measuring differences in light absorbance by the conjunctiva of the eye in the 
wavelength range 460 to 600nm for online monitoring of jaundice and a similar approach was used for 
hemoglobin estimation (Sarkar et al 2017). Pratesi et al (2015) have employed BiliCareTM system which 
uses green and blue light emitting diode (LED) sources to measure the ratio of light intensity before 
and after transmission through a neonate’s ear lobe and compared it with a JM-103TM system  which 
uses a xenon lamp and measures the green and blue light components reflected from a neonate’s 
forehead. In addition a xenon lamp and LED have been used for addressing light reflected from the skin 
(Biliscan 2017), more recently a smartphone camera has been used for obtaining an image of a neonate’s 
torso with ambient light (de Greef et al 2014, Taylor et al. 2017) from which the colour of the skin was 
determined and related to the bilirubin level.. 
Such devices could reduce the number of hospital readmissions (Petersen et al 2005) and decrease the 
amount of required blood samples from patients (Maisels and Kring 1997).Their use is recommended 
in clinical practice guide lines on the management of hyperbilirubinemia (Maisels et al 2004). However, 
no transcutaneous bilirubin meter has yet evolved with sufficient reliability for reducing the usage of 
invasive blood sampling through a preliminary assessment of bilirubin level in vivo. Performance 
improvements of TcB methods remain to be sought (de Greef et al 2014, Bosschaart et al 2012) 
particularly with regard to indicating the need for detailed blood testing. 
The present contribution addresses this need for a more reliable approach for the preliminary optical 
monitoring of skin tissue bilirubin. The approach is based upon a non-linear form of chromatic analysis   
(Deakin et al 2014, Jones et al 2009a, Elzagzoug et al 2014, Lo et al 2017) which derives from initial 
chromatic investigations at the Royal Liverpool Women’s Hospital in 1998 (Jones et al 2008).  It uses 
a light tight housing containing LEDs for illumination and an optical reference template onto which a 
mobile phone camera can be attached. The template assists in automatically tuning the mobile phone 
camera plus providing measurement references. The unit carries a transparent plastic window through 
which an occluded tissue area (e.g. nose, forehead, abdomen) is addressed. The approach can be used 
with different types of mobile phone cameras, has good reliability and has a potential for use remote 
from medical hospitals.  
Preliminary results for bilirubin levels obtained with this system for 48 neonates and 6 different types 
of mobile phone cameras are presented and compared with the Bilirubin levels determined from blood 
tests. 
2. Experimental Methods  
2.1 Optical Measurement Technique 
 
The optical measurement technique used in the present study was based upon chromatically monitoring 
white light from a group of Light Emitting Diodes (LEDs) reflected /scattered from the skin tissue of a 
neonate in vivo using a mobile phone camera. A schematic diagram of the in vivo tissue monitoring 
system is shown in figure 1(a).  
The system consisted of a removable mobile phone camera mounted upon a light tight housing for 
monitoring a reference template carrying a rigid plastic window at the other end of the light tight 
enclosure. The rigid plastic window was pressed against the tissue under test (e.g. neonate nose) in 
order to occlude haemoglobin from the tissue and so enhance the optical influence of the tissue. The 
template, including the plastic window was illuminated by an array of white light surface mount diodes 
arranged in a strip (0.2W, from Sunlux Energy ltd) and circled around an aperture (figure 1 (a)) through 
which the camera lens observed and captured an image of the template and window. 
 
 
Figure 1. Optical measurement system and image produced 
(a) Schematic diagram of the system layout 
(b) Typical images captured by a mobile phone camera of Wo (set Bl = 0), 
W2 (set Bl = 10mg/dl) and WT (neonate nose tissue) in the sample window 
and set references ro = (set Bl  0), r2 = (set Bl  10) 
 
The template consisted of a colour printed-paper with a rectangular and rigid sample viewing plastic 
window (figure 1 (b)). The printed paper had several sectors with different chromatic signatures, which 
were empirically chosen, along with some alignment assisting features. Two template sectors adjacent 
to the plastic window had chromatic signatures chosen empirically from occluded skin images of two 
neonates one without jaundice (ro) and one with 10mg/dl bilirubin (r2). These areas provided an 
indication relative to a sample in the window as to whether the camera settings etc. had varied so that 
compensation could be made. The remaining template areas were empirically coded to accommodate 
automatic image adjustments made by the camera operating system and which could vary for different 
cameras.  
The 6 mobile phone cameras used in the tests are listed on Table 1 A, Appendix 1 along with the pixel 
density and the number of different neonates tissues addressed by each camera. Each mobile phone 
camera was operated in “auto mode” so that the exposure time was automatically set. Geometric 
alignment features on the template (figure 1 (b)) (red dots, square black frame) enabled the camera to 
be checked for correctly addressing relevant areas on the template sectors (ro, r2, W figure 1 (b)) for 
chromatic analysis.  
Relevant areas of sectors on the image captured by the mobile phone camera (sample window (WT), 
reference sectors (ro, r2) figure 1(b)) produced outputs for three parameters (R, G, B) whose wavelength 
responses were non-orthogonal as shown on figure 2 and covered the wavelength ranges of various skin 
tissue components (bilirubin, hemoglobin, melanin (Bhutani et al 2000)). The R, G, B outputs were 
processed to yield chromatic parameters X, Y, Z and L to quantify the variation between different 
images. X, Y, Z and L are defined by (Jones et al 2008). 
   𝐿 = (𝑅 + 𝐺 + 𝐵)/3                                                                       (1) 
𝑋 = 𝑅/3𝐿;   𝑌 = 𝐺/3𝐿;    𝑍 = 𝐵/3𝐿                                                (2) 
This enabled features of complicated spectra to be defined and quantified in terms of a limited number 
of parameters whilst remaining sensitive to the growth of unexpected spectral features and events. 
Sensor responses and chromatic parameters may be selected for highlighting the required information 
(Deakin et al 2014, Jones et al 2009a, Elzagzoug et al 2014, Lo et al 2017). The chromatic parameters 
X, Y, Z may be represented on a two dimensional chromatic map, for example a graph of Y against Z 
which emphasises variations at short / medium wavelengths (B, G) with respect to the overall 
wavelengths (B, G, R). The bilirubin spectrum is mainly covered by the B and G detectors, while the 
hemoglobin and melanin spectra extend across the B, G and R detectors (figure 2).   
 
Figure 2. Typical overlapping wavelength responses (R, G, B) of an electronic camera 
relative to wavelength ranges of some skin tissue components (Bilirubin (Bl), Hemoglobin 
(He), Melanin (Me). 
The image captured by the mobile phone camera could be transmitted to a remote central hub computer 
for chromatic processing and derivation, via calibration, of the bilirubin level (indicative of jaundice) 
in the tissue. The result was automatically transmitted back to the sender within a couple of seconds so 
enabling the mobile phone system to be utilised at rural regions remote from a medical hub. 
The setting up procedure for using the camera system involved automatically checking for image 
acceptability with regard to the reference sectors (ro, r2) (figure 1 (b)) and with paper reference samples 
of “normal” neonate skin Wo (Bl ~ 0 mg/dl) and skin with moderate bilirubin level W2 (Bl ~ 10mg/dl) 
sequentially in the sample window. When introducing a new camera etc. three images were captured 
corresponding to three different samples in the template window, namely paper representations of Wo 
and W2 plus a real skin tissue WT (figure 1 (b)). The R, G, B values for a specified area  on each of the 
sectors (ro, r2, W) were automatically extracted, stored and used to calculate the chromatic parameters 
X, Y, Z for further analysis by the computer software. 
2.2. Test Procedures  
Tests were conducted on 48 newly born babies by clinicians at the Ovum Hospital, Bangalore, India 
and coordinated via the Thengana Medical Mission Hospital and Research Centre, Karala (TMMHRC). 
The subjects were drawn from infants born at the Ovum Hospital, Bangalore, who weighed at least 
2500 g at birth, with a gestational age of at least 36weeks The cases were infants with a maximum TSB 
level of 16 mg/dl in the first 3 days after birth. Infants were excluded if they were receiving 
phototherapy.   
Tests were conducted in accordance with ethical principles in the Declaration of Helsinki. Ethical 
approval was given via the Independent Ethics Committee Consultants (IECC) organised and operated 
according to the requirements of ICH – GCP, Indian Council of Medical Research. After the physician 
ordered a Total Serum Bilirubin (TSB) for clinical purposes, informed consent was obtained from a 
parent.  The objectives and detailed procedures were explained to each parent in simple language and 
a copy provided to the parent entering the study which was signed by the parent. 
For the optical camera tests, the tissue at the nose, forehead and abdomen of each neonate was occluded 
by pressing the stiff plastic sample window of the monitoring template against the neonate skin. 
Following a camera test, blood samples were collected from neonates by veni puncture and were sent 
to the clinical laboratory at site for analysis. Serum was separated from blood and mixed with standard 
diazo regent to form coloured compound (Puppalwar et al. 2012, Watson 1961). TSB levels were then 
measured with an abachem 200 semi-automated biochemistry analyser (abaxis healthcare ltd, India).   
2.3. Operation of the Monitoring Unit 
Details of the deployment of the mobile camera and template unit for the in vivo testing of a tissue 
sample was as follows – 
a) A mobile phone camera was positioned on top of the template unit (figure 1(a)) and the 
geometric alignment of the frame and orientation was checked visually on the camera screen 
and adjusted by zoom camera control in order to capture the template image (figure 1(b)). 
Acceptable Images were automatically determined with the operating software. 
 
b) When testing with a new mobile phone camera, the unit was first used to address two calibration 
samples in the sample window. These were paper printed versions of 0 and 10 mg/dl bilirubin 
levels (Wo, W2 (figure 1 (b)) chromatically identical to reference areas ro, r2 (but with optical 
transmission through the plastic window). 
 
c) Images of Wo and W2 were captured by the camera from which R, G, B values of fixed areas 
on the window (Wo, W2) and the reference (ro, r2) sectors were derived.    
Since the 6 different mobile phone cameras used in the tests had various pixel densities 
(Appendix 1, Table 1 A) the number of pixels (Np) addressed within the chosen monitored area 
from which the R, G, B values were calculated were determined using a fixed area ratio (A), 
which varied with the pixel density (Nc) of the particular type of camera (i.e. Np = Nc / A). Np 
was automatically determined with the operating software.  
 
d) The skin tissue to be tested was occluded by pressing the plastic sample window onto the tissue 
and an image captured with the camera to obtain the R, G, B values of the sample (Wt) and the 
corresponding two reference sectors (ro, r2). 
 
e) The R, G, B values for the camera calibration and tissue sample (sections (c ) and ( d) above) 
images were transmitted directly from the mobile phone to a hub computer which checked for 
correct operation, image alignment and calculated values of relevant chromatic parameters (Z, 
Y) from the R, G, B captured values (equations (1), (2)). 
 
f) The corrected chromatic parameters yielded bilirubin values by calibration with the 0 and 
10mg/dl bilirubin paper samples values ((c). above). 
 
g) The calculated bilirubin value Bl was automatically transmitted back to the user via the mobile 
phone application, the entire process only taking a few seconds. 
 
h) The user was also automatically informed of any errors due to misalignment, unsuitable image 
etc.   
Tests were performed on 48 different neonates by clinicians using mobile phone of their own choice. 
As a result the 6 different mobile phone cameras listed on Table 1 A, Appendix 1 were randomly used 
in the tests, the number of neonates monitored with each camera being indicated on the table.  
 
3. Test Results and Data Analysis 
 
The test results were analysed using two chromatic methods – Primary and Secondary Chromatic 
analysis. The Primary Chromatic analysis utilised the ratio of the medium wavelength parameter Y to 
the short wavelength parameter Z (cf. Pratesi et al 2015). The Secondary Chromatic Analysis utilised a 
more sophisticated correction procedure along with a non-linear calibration. 
3.1Primary Chromatic Analysis 
 
The Primary Chromatic analysis involved determining the medium and short wavelength chromatic 
parameters (Y, Z) from the R, G, B values of the window with a tissue sample (WT) (equations (1), (2) 
and Section 2.3). Y, Z values were also obtained for images of set paper references Wo (Bl = 0) and 
W2 (Bl = 10mg/dl) in the window (figure 1 (b)) which were used to provide a linear calibration of (Y/Z) 
versus bilirubin level. The Primary Chromatic bilirubin level (PChBl) is then given by.    
𝑃𝐶ℎ𝐵𝑙 = [(𝑌/𝑍)(𝑊𝑇) − (𝑌/𝑍)(𝑊𝑜)]/[(𝑌/𝑍)(𝑊2) −  (𝑌/𝑍)(𝑊𝑜)]     (3) 
Where (Y/Z)(WT) = ratio of Y to Z with the tissue sample in the window (WT) 
            (Y/Z(Wo) = ratio of Y to Z with 0mg/dll Bl paper reference in the window (Wo) 
            (Y/Z(W2) = ratio of Y to Z with 10mg/dl paper reference in the window (W2) 
 
Bilirubin values PChBl were obtained with equation (3) for the tests with 48 neonates each with one of 
the 6 different types of cameras (Table 1A, Appendix 1) as preferred by the clinician performing the 
test. The results are shown on figure 3 as a function of TSB levels obtained for each neonate from blood 
tests with the camera type used identified by the various symbols shown on Table 1A, Appendix 1. The 
skins were all occluded to reduce hemoglobin influence although melanin effects may have remained. 
This figure also shows, as dashed lines, the 95% Prediction Interval boundaries PI(95%) which define 
the scatter of the data from the fitted regression line (Altman 1991). The results show a high degree of 
scatter which may be due to several factors including the use of different types of cameras and possibly 
different melanin levels in individual neonates. 
 
 
Figure 3. Primary Chromatic Bilirubin level (PChBl) versus Total Serum Bilirubin 
TSB(mg/dl). (Results for 48 neonate tests with 6 different phone cameras; each camera type 
designated by symbols from Table 1A). Solid line: Regression line, Dashed lines: Prediction 
Interval boundaries PI(95%) 
3.2 Secondary Chromatic Analysis 
 
The Secondary Chromatic analysis seeks to take account of additional complex factors which may 
adversely affect the accuracy of the bilirubin levels estimated from the camera images. For example, 
not only do various cameras have different pixel densities (Table 1A, Appendix 1) but they may also 
have different relative numbers of R, G, and B pixels per unit area. The effect of such pixel variation, 
as well as other factors (e.g. window plastic quality, condition etc.), may be illustrated on a chromatic 
Y : Z map for the window addressed paper samples corresponding to 0 (Wo) and 10mg/dl (W2) bilirubin 
levels (figure 1 (b)). Figure 4 shows the Y : Z values derived with equations (1), (2) from the R, G, B 
values for Wo and W2 for each of the 6 mobile phone cameras used in the 48 neonates tests.   
Also shown on figure 4 are the Y, Z window reference values Wo, W2 (figure 1 (b)) for an additional 6 
mobile phone cameras listed on Table 1B, Appendix 1. These mobile phone cameras were not used in 
the neonate tests but are presented to show how the 6 tissue tests cameras are representative of a wider 
range of cameras. These results show the variability of the Wo – W2 loci obtained when using different 
mobile phone cameras compared with the locus of the set values of the paper references So – S2. The 
(So – S2) locus differs from the window loci (Wo – W2) due to the plastic window and other effects. 
 
Figure 4.  Chromatic Y : Z map showing set reference areas locus (So-S2) and set sample 
window loci (Wo-W2) for 12 different cameras  with set reference (So-S2),  6 mobile phone 
cameras used in the neonate tests (Table 1A, Appendix 1) full lines, 6 mobile phone cameras 
used in reference tests only (Table 1B, Appendix 1) dashed lines. 
The Secondary Chromatic analysis takes account of these various features. It involves two parts, namely 
the production of Correction Factors (CF) for the Z and Y chromatic parameters, and the calibration of 
the corrected Z and Y values to yield Secondary Chromatic Bilirubin levels (SChBl). 
3.2.1. Correction Factors (CF). A procedure for correcting a test result obtained with a given camera, 
plastic window etc.to the set locus (So – S2) is illustrated on figures 5 (a), (b) and (c). These show 
chromatic maps based upon Y, Z parameters (equations (1), (2)) whose values were calculated from the 
R, G, B image values.   
 
The procedure involved determining separate Correction Factors (CF(Z), CF(Y)) for the chromatic 
parameters  Z and Y from the window paper references (Wo, W2) for a camera, relative to the set 
references (So,S2) (figure 5 (a)). The Correction Factors were defined as  
For Wo   Z correction                   (𝐶𝐹(𝑍, 𝑊𝑜)) = (𝑍𝑆𝑜)/(𝑍𝑊𝑜)                            (4.1)  
               Y correction                   (𝐶𝐹(𝑌, 𝑊𝑜)) = (𝑌𝑆𝑜)/(𝑌𝑊𝑜)                             (4.2) 
For W2   Z correction                   (𝐶𝐹(𝑍, 𝑊2)) = (𝑍𝑆2)/(𝑍𝑊2)                             (4.3) 
               Y correction                   (𝐶𝐹(𝑌, 𝑊2)) = (𝑌𝑆2)/(𝑌𝑊2)                             (4.4) 
The Z, Y coordinates of a tissue sample (WT) corrected with respect to S2 for example (figure 5 (b)) 
then become 
  Z coordinate                                   𝑍( 𝑊𝑇∗2) = 𝑍(𝑊𝑇) . (𝐶𝐹(𝑍, 𝑊2)))                    (5.1) 
 Y coordinate                                    𝑌(𝑊𝑇∗2) = 𝑌(𝑊𝑇) . (𝐶𝐹(𝑌, 𝑊2)))                        (5.2)  
In practice the Z, Y coordinates can also be corrected with respect to So with equations of the same 
form as equations (5.1), (5.2). A procedure is therefore needed for selecting the most appropriate 
Correction Factors from equations (4.1) – (4.4) and is illustrated on the Y : Z map of figure 5 (c) . This 
shows the Y, Z coordinates of a tissue sample (WT) relative to the locus of the reference sectors 
coordinates (ro(T), r2(T) with the tissue sample (WT) in the test window. The CF choice is based upon 
whether WT is nearer to ro(T) or r2(T) along the Y and Z axes.  
For example, figure 5 (b) shows a tissue sample (WT) located relative to the paper calibrating images 
(Wo, W2) and set values (So, S2) (already shown on figure 4). In this case, the tissue corrected (WT)* 
was determined with the Correction Factors CF(Z, W2), CF(Y, W2) since Z(WT) was closer to r2(T) 
than ro(T) (figure 5 (c )).  
The correction procedure described above is summarised on the chromatic analysis flow chart of 
figure 6. 
  Figure 5. Correction of chromatic Y:Z values obtained from camera images  
(a) Example of a set window locus (Wo-W2) corrected to the set references locus (So-S2) using 
Samsung (Galaxy SM J10) mobile camera 
(b) Example of deployment of a Correction Factor (CF(Z, W2) for a given tissue sample (WT) 
(c) Procedure for choosing the most appropriate Correction Factor (CF) for a tissue sample WT 
with respect to reference areas ro, r2 
 
 Figure 6. Chromatic analysis flow chart   
 
3.2.2. Secondary Chromatic Calibration Graphs. Calibration of the corrected secondary chromatic 
parameters (Y(WT)*, Z(WT)*) was achieved with graphs of Y(WT)* and Z(WT)* versus the 
corresponding blood TSB level. Such calibration graphs have been produced using the 48 neonate 
samples investigated and are shown on figures 7 (a) for Y(WT)* and7 (b) for Z(WT)*. These graphs 
highlight  
(a) The non-linear variations of both Y(WT)* and Z(WT)* with blood (TSB). 
(b) The opposite trend of Y(WT)* and Z(WT)* with blood (TSB). 
The preferred estimate of bilirubin level derived from the chromatic results (SChBl) is taken as the 
mean of the Y and Z derived values i.e. 
   𝑆𝐶ℎ𝐵𝑙 = [𝑌𝐶ℎ(𝐵𝑙) + 𝑍𝐶ℎ(𝐵𝑙)]/2                                                  (6) 
 
 
Figure 7. Calibration graphs for corrected (WT)* as a function of Total Serum 
Bilirubin TSB (mg/dl). (a) Y(WT)* : TSB, (b) Z(WT)*: TSB (Mobile phone camera 
type indicated by symbol of graphical point, Table 1A, Appendix 1) 
Figure 8 shows values of the bilirubin levels determined from the test results using the Y(WT)* and 
Z(WT)* calibration graphs of figure 7 (SChBl) as a function of the TSB for the 48 test cases. Also 
shown on figure 8 as dashed lines are the 95% Prediction Interval boundaries PI(95%)  from the fitted 
regression line (Altman 1991). The scatter of results (e.g. due to melanin etc.) are visible but to a 
lesser extent than with the Primary Chromatic analysis. 
 
 
Figure 8 Corrected Secondary Chromatic Bilirubin (SChBl) versus Total Serum Bilirubin 
(TSB) mg/dl (48 neonates tests, 6 different phone cameras: camera type indicated by symbol 
of graphical point Table 1A, Appendix 1) Solid line: Regression line, Dashed lines: Prediction 
Interval boundaries PI(95%) 
 
4. Discussion of Results  
 
The results of the Primary and Secondary Chromatic analysis (figures 3 and 8) may first be compared 
with blood test results and optical skin results reported by other researchers then (e.g. Pratesi et al 2015, 
de Greef et al 2014). The comparisons are based upon a Linear Regression analysis (Altman 1991), 
Bland – Altman plot (Bland et al 1986) and values of Sensitivity (Sn), Specificity (Sp), Positive 
Predictive Value (PPV), Negative Predictive Value (NPV) (e.g. Deakin etal 2014) (Appendix 2). 
4.1 Primary Chromatic Results 
A comparison of the Primary Chromatic skin results with the blood test results was first made using a 
Linear Regression analysis via (SPSS v.21 statistical software) and the results are shown on Table 1. 
The Primary Chromatic results have a correlation (R2) of 0.43, 95% Confidence Interval CI(95%)                        
(0.43 – 0.88) and a significant level P < 0.0001 and F = 34.4. Also the experimental Primary Chromatic 
results of figure 3 show 95% Prediction Interval boundaries PI(95%) of ±9 (mg/dl).  
Results from a Bland – Altman plot for the Primary Chromatic analysis are also shown on Table 1. 
These show that the Mean Difference (MD) between the Primary Chromatic analysis and TSB is (-1.24) 
with 95% Confidence Interval CI(95%) (0 – -2.47) and Limits of Agreement LoA (-7.5 – 5). 
 
Table 1. Performance of Primary (PChBl) and Secondary (SchBl) Chromatic Analysis 
compared with blood TSB results for 48 neonates. (Linear Regression: R, R2=Correlation 
Coefficient, Cl(95%) = 95% Confidence Interval, F,P=Statistic Significant Values; Bland-
Altman Plot: MD= Mean Difference,  LoA= MD ±1.96 x standard deviation of difference, 
Cl(95%) = 95% Confidence Interval) 
 
Statistical Analysis 
Method 
Primary Chromatic Analysis 
(PChBl) 
Secondary Chromatic Analysis 
 (SChBl) 
 
Linear Regression 
 
R = 0.65   CI(95%) 0.43 – 0.88 
R2 = 0.43                
F = 34.4  P= 4.7*10-7 
 
R = 0.9    CI(95%) 0.77 – 1.03 
R2 = 0.81              
F = 190.6  P= 5.7*10-18 
Bland – Altman Plot  MD = - 1.24   CI(95%) 0  – -2.47                 
LoA = -7.5 to 5  CI(95%) ± 2.13             
MD = 0.28 CI(95%) 0 – 0.56        
LoA = -2.9 to 3.5  CI(95%) ± 0.49 
 
4.2 Secondary Chromatic Results 
A comparison of the Secondary Chromatic skin results with blood test results was also made using a 
Linear Regression analysis via (SPSS v.21 statistical software) and the results are also shown on Table 
1. These results have a strong correlation (R2) of 0.81, CI(95%) (0.77 – 1.03) and a significant level P 
< 0.0001 and F = 190. Also the Secondary Chromatic results of figure 8 show PI(95%) of only ±3 
(mg/dl). 
Results from a Bland – Altman plot (Appendix 3) for the Secondary Chromatic analysis are also shown 
on Table 1. These show that the MD between the Secondary Chromatic analysis and TSB is (0.28) with 
CI(95%) (0 – 0.56) and LoA (-2.9 – 3.5). The positive bias along with the CI indicates that the 
predominant tendency of the Secondary Chromatic approach is to slightly overestimate the bilirubin 
levels so providing a fail-safe indication of the bilirubin level 
4.3. Comparison of the Primary and Secondary Chromatic Analysis Results 
A comparison of the Primary and Secondary Chromatic analysis (Table 1) shows that the correlation 
(R2) for the Secondary Chromatic analysis has improved from 0.43 to 0.81, the CI(95%) has improved 
from (0.43 – 0.88) to (0.77 – 1.03) and the PI(95%) boundaries has improved from ±9 (mg/dl)                     
(figure 3) to ±3 (mg/dl) (figure 8). The correlation and prediction intervals show that the Secondary 
Chromatic analysis substantially improves the results giving significant correlation with the TSB 
results.  
In addition the Bland - Altman results show that the Secondary Chromatic analysis has a MD of (0.28) 
compared to (-1.24) for the Primary Chromatic analysis, a CI(95%) of (0 – 0.56) compared with                          
(0 – -2.47) and a LoA (-2.9 to – 3.5) compared to (- 7.5 to 5).  
4.4. Comparison of the Secondary Chromatic Results with Other Published Results  
A comparison of the Secondary Chromatic results with those obtained with different optical approaches 
by other researchers may be made in terms of values for the Linear Regression correlation coefficient 
(R2), Sensitivity (Sn), Specificity (Sp), Positive Predictive Value (PPV) and Negative Predictive Value 
(NPV) (Appendix 2). Values of these parameters have been determined with respect to a critical 
bilirubin level of 10 mg/dl which corresponds to a typical TSB level of concern for neonates of age 
after birth up to 48 hours defined by TSB Nomogram (Bhutani 2000).  The Secondary Chromatic results 
are compared with those reported by Pratesi et al (2015) (Bilicare, Minolta JM-103) and de Greef et al 
(2014) (Bilicam phone) on Table 2. 
Table 2. Comparison of Secondary Chromatic analysis results with other published results. 
R2 = Linear Regression Correlation, Sn = Sensitivity, Sp = Specificity, PPV = Positive 
Predictive Value, NPV= Negative Predictive value for a critical bilirubin level 10 mg/dl. 
Source No. 
Tests 
R2 Sn Sp PPV NPV 
1. (Pratesi et al 2015) 
(a) Bilicare 
(b) Minolta JM-103 
    
97 0.31 0.96 0.4 0.86 0.73 
 
98 0.49 0.81 0.74 0.83 0.73 
2. (de Greef et al 2014) 
Bilicam (phone) 
   
100 0.71 0.82 0.8 0.81 0.81 
3. Secondary Chromatics 
Analysis SCh(B)l 
  
 
48 0.81 0.97 0.82 0.95 0.90 
 
The Secondary Chromatic results have high values of Sensitivity (0.97), Specificity (0.82), PPV (0.95) 
and NPV (0.90) indicating a high capability for identifying critical cases. These values are higher than 
the values quoted by Pratesi et al (2015) (Bilicare, Minolta JM-103) and de Greef et al (2014) (Bilicam 
(phone)). Also the correlation coefficient (R2) of the Secondary Chromatic results (0.81) is higher than 
those of the Pretesi and de Greef value (0.31 – 0.71). 
Taylor et al (2017) have more recently quoted good results for a Bilicam system but based upon a higher 
critical Bilirubin level of 17 mg / dl rather than the 10 mg / dl critical level for the present results.  
4.5. Results with Different Mobile Phone Cameras 
The results presented were obtained with 6 different types of mobile phone cameras (Appendix 1). 
These show that the non-linear Secondary Chromatic analysis accommodates the use of these different 
cameras to provide bilirubin level results which are largely independent of the type of camera used. 
Checks made with a further 6 different cameras using only reference images (Appendix 1) indicate that 
the camera responses are similar to the 6 cameras used in the skin tests. Thus reliable skin tissue results 
should be produced from a larger range of different cameras than the limited number of cameras used 
in the present tests.      
4.6. Effects of Other Skin Tissue Component  
Skin tissue components, other than bilirubin, can affect the values of the chromatic parameters X, Y, Z, 
L. In the present tests, the effect of haemoglobin (figure 2) was reduced by occluding the skin tissue. 
The effect of melanin is partly taken into account via the set calibrations (So, S2) because the values of 
these parameters were derived from images of real neonate skin tissue which contained melanin and 
not based upon pure bilirubin spectra. The correction procedure with the Secondary Chromatic analysis 
(Figures 5) appears to reduce the effect of any melanin variations between different neonates. This is 
apparent as a reduced scatter of the results which lie within PI(95%) boundaries ± 3mg/dl (figure 8). 
Larger variations in melanin levels due for instance to different ethnic skins will require further study. 
The effect of biliverdine occurrence in the skin should also be investigated further. The chromatic 
approach has sufficient flexibility for accommodating such effects as further empirical information 
emerges by, for example adjustments to the chromatic calibrations, more detailed attention to longer 
wavelengths via the R parameter etc. 
 
5. Conclusions 
 
It has been shown that the skin jaundice of a neonate can be monitored using a new chromatic analysis 
of data obtained with a mobile phone and a novel template (Shabeer et al 2016).  
 
A non-linear form of the chromatic analysis produces skin tissue results (TcB) which are in good 
agreement with blood analysis (TSB) results having a high correlation (R2) of 0.81 and a mean 
difference (MD) of 0.28 mg/dl. The results indicated that neonates with bilirubin levels above a 
medically regarded critical level 10 mg/dl early after birth could be identified with a high degree of 
Sensitivity (0.97), Specificity (0.82), PPV (0.95) and NPV (0.9) higher than those reported to date with 
other optical systems Pratesi et al (2015) (Bilicare, Minolta JM-103) and de Greef et al (2014) (Bilicam).  
 
The method has been shown to be useable with at least 6 different types of mobile phones. 
Bilirubin levels can be distinguished to within ±3 mg/dl which is sufficient to provide an indication as 
to whether a more detailed bilirubin blood test should be sought.  
Further investigations should include the use of a greater variety of mobile phones than the 6 phones 
already tested, addressing a wider variety of ethnic skins, applications to skin conditions following 
phototherapy etc. 
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APPENDIX 1 
Camera used in the study along with their pixel densities  
Table 1A.  Mobile phone cameras and their resolutions used in the chromatic tests on 48 neonates 
Phone Camera Model Resolution  
(Mega-Pixels) 
Symbol Number of tests 
Apple (iPhone 4) 0.8 ● 1 
Samsung (GT-S6802) 1.2 ▲ 10 
Samsung (SM-J200G) 3 + 2 
Micromax (A-106) 5 *  1 
Xiomi (Redmi 2014818) 8 ■ 20 
Oneplus (ONE-E1003) 8.3 ♦ 14 
 
 
Table 1B. Additional Mobile phone cameras and their resolutions used only for addressing references 
(Wo, W2) for supplementary information 
Phone Camera Model Resolution  
(Mega-Pixels) 
Symbol 
Samsung (Galaxy SMJ 10)                             3 ○ 
LG (P875)                                                       1 ×  
Samsung SM-J2L10F)                                   8 ◊ 
Samsung (SM-J200G)                                   5 − 
Lenova (A2010a)                                             0.7 □ 
Micromax (A106)                  0.7 ∆ 
 
 
APPENDIX 2   
Formula for Sensitivity, Specificity, PPV, NPV 
Sensitivity (Sn), Specificity (Sp), Positive Predicted Value (PPV), Negative Predicted Value (NPV) are 
defined by the following equations (e.g. Deakin et al (2014)) 
𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 (𝑆𝑛) = 𝑇𝑃(𝐶ℎ𝐼)/(𝑇𝑃(𝐶ℎ𝐼) + 𝐹𝑁(𝐶ℎ𝐼))                                                       (A.1) 
𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 (𝑆𝑝) = 𝑇𝑁(𝐶ℎ𝐼)/(𝑇𝑁(𝐶ℎ𝐼) + 𝐹𝑃(𝐶ℎ𝐼))                                                        A.2) 
𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑃𝑟𝑒𝑑𝑖𝑐𝑖𝑡𝑒𝑑 𝑉𝑎𝑙𝑢𝑒 (𝑃𝑃𝑉) = 𝑇𝑃(𝐶ℎ𝐼)/(𝑇𝑃(𝐶ℎ𝐼) + 𝐹𝑃(𝐶ℎ𝐼))               (A.3) 
𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑃𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑 𝑉𝑎𝑙𝑢𝑒 (𝑁𝑃𝑉)  = 𝑇𝑁(𝐶ℎ𝐼)/(𝑇𝑁(𝐶ℎ𝐼) + 𝐹𝑁(𝐶ℎ𝐼))            (A.4) 
Where TP(ChI), FP(ChI) are respectively the number of True, False positive chromatic results                            
(Bl > or = 10). 
TN(ChI), FN(ChI) are respectively the number of True, False negative chromatic results (Bl <10) 
(ChI – Chromatic Indicator) 
 
APPENDIX 3   
Bland-Altman Plot (Secondary Chromatic analysis) 
A Bland – Altman plot for the Secondary Chromatic analysis is shown on figure A3.1. This figure 
shows a graph of the difference between the bilirubin results of the Secondary Chromatic analysis 
(SChBl) and the TSB results (i.e. (SChBl minus TSB) plotted against their average 
The MD between the chromatic and TSB results is represented on figure A3.1 as the separation of the 
two horizontal solid lines which has a value of (0.28) and with a CI(95%) of (0 – 0.56).  
Figure A3.1 also shows the LoA between the Secondary Chromatic and TSB results as two dashed 
horizontal lines (based upon MD ± 1.96 standard deviation of the difference). This shows that the 95% 
difference lies between the limits (-2.9) – (3.5) mg/dl. Thus 95% of neonates tested with the Secondary 
Chromatic approach would be indicated to have between 2.9 units less and 3.5 units greater than the 
blood TSB measurement.  
 
Figure A3.1.  Bland-Altman plot showing the difference between Secondary Chromatic 
bilirubin (SchBl) and TSB blood measurements against their average. Difference of 
measurements = [SchBl Minus TSB]; Average of measurements = [(SchBl + TSB) / 2]; Solid 
black lines: MD and (CI 95%); Dashed lines: Limit of Agreement (LoA) 
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